Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Transfusion|March 13, 2021
The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus-6B encephalitis after naïve T-cell-depleted allogeneic stem cell transplantationMercedes Gasior, Cristina Ferreras, Raquel de Paz, et al.
BMJ Open|January 11, 2020
Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemiaMario Muñoz Builes, María Vela Cuenca, Jose L Fuster Soler, et al.
Frontiers in Immunology|November 6, 2023
NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cellsMarta Ibáñez-Navarro, Adrián Fernández, Adela Escudero, et al.
Scientific Reports|March 7, 2017
The syndrome of central hypothyroidism and macroorchidism: IGSF1 controls TRHR and FSHB expression by differential modulation of pituitary TGFβ and Activin pathwaysMarta García, Raquel Barrio, Montserrat García-Lavandeira, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 21, 2021
Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL-Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic LeukemiaLara Maria Gómez García, Adela Escudero, Carmen Mestre, et al.
Ebiomedicine|August 3, 2025
Tandem CD19/CD22 CAR T-cells as potential therapy for children and young adults with high-risk r/r B-ALLBerta González-Martínez, Víctor Galán-Gómez, Alfonso Navarro-Zapata, et al.
Frontiers in Pediatrics|October 6, 2023
The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP)Pablo Velasco, Francisco Bautista, Alba Rubio, et al.
Journal of Hematology & Oncology|July 2, 2025
CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemiaNéstor Tirado, Klaudyna Fidyt, María José Mansilla, et al.
Frontiers in Pediatrics|February 22, 2021
Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on TreatmentNerea Vega-García, Sara Perez-Jaume, Elena Esperanza-Cebollada, et al.
Pageof 3